essential for Hh signalling and that, in the absence of Ptc, Smo is constitutively active [5, 6] . Murone et al. [8] have shown that overexpression of vertebrate Smo in Hhresponsive tissue culture cells is sufficient to activate transcription of a Gli-dependent reporter gene, an effect that can be abrogated by co-transfecting the cells with a Ptc cDNA. Moreover, it was reported that Ptc and Smo could be co-immunoprecipitated from such cells [8] , suggesting that Ptc suppresses Smo activity by a direct physical interaction. We have addressed this 'sequestration' model in vivo by overexpressing smo in alternate segments of the developing Drosophila embryo. Sequence encoding the FLAG epitope tag was added near the 5′ end of the fulllength Drosophila smo cDNA, which was then cloned into the UAS transformation vector pUAST [13] . Transgenic flies carrying this construct were crossed to flies homozygous for h-Gal4, which in the embryo drives expression of the GAL4 transactivator in alternating segment-wide domains under the control of regulatory elements of the pair-rule gene hairy (h) [13] (see Figures 1a and 2i) .
Transcription of the wingless (wg) gene, a principal target of Hh signalling in the embryo, is restricted to cells immediately adjacent to those expressing Hh (see Figure 2i ). Elimination of Ptc activity or ectopic expression of Hh results in the expansion of each wg domain, such that they come to occupy approximately half of every segment [14, 15] . We therefore analysed wg expression in the h-Gal4;UAS-smo embryos to determine whether wg expression is ectopically activated in alternate segments in response to the overexpression of Smo. Contrary to expectation, we found no evidence of ectopic activation of wg, the embryos displaying an essentially wild-type pattern of expression ( Figure 1b) . Moreover, such h-Gal4;UAS-smo animals completed embryogenesis and developed into viable adults (data not shown). A trivial explanation of the failure of the overexpressed cDNA to activate the Hh pathway could be that the activity of the encoded protein has been compromised in some way, for instance, by addition of the epitope tag. To exclude this possibility, we tested its ability to rescue smo loss-of-function mutations. Expression of the tagged cDNA under the control of the ubiquitous arm-Gal4 driver [16] rescued fully the cuticle phenotype of homozygous null smo embryos (data not shown). Expression of the same transgene under the control of h-Gal4 in a smo null background rescued the cuticular phenotype in alternate segments (Figure 1c,d ).
To analyse the expression of the endogenous Smo protein, we raised an antibody against the membrane-proximal portion of the putative intracellular carboxy-terminal tail of Smo (anti-SmoC antibody; see Figure 3d ) and used this to stain wild-type and transgenic embryos. In contrast to the ubiquitous distribution of the smo mRNA (Figure 2a Note the elevated levels of staining in six stripes in alternating segments in the thoracic and abdominal region (dots) corresponding to parts of hairy stripes 2-7 (see Figure 1a) , and the two additional domains of elevated expression in the cephalic region (asterisks), which fall within hairy domain 1 (see Figure 1a) . simultaneously with the anti-SmoC antibody and monoclonal antibodies for Engrailed (En) [17] , a marker of Hhexpressing cells [18] , and Wg [19] , a marker of Hh-responding cells [14] . Double staining with the antiEn antibody revealed that Smo accumulates in and around cells expressing En ( Figure 2d ,h); double staining with the anti-Wg antibody showed that Smo also accumulates in cells expressing Wg (Figure 2g ). [20] . Such embryos displayed a ubiquitous expression of Smo between parasegments 5 and 9, precisely the region in which ectopic Hh expression is driven by the Kr-Gal4 driver ( Figure 2f ). As Hh acts by inhibiting Ptc activity, the effects of Hh on Smo would be expected to be mediated by Ptc. In embryos homozygous for a ptc loss-of-function mutation, the modulated pattern of staining typical of the wild type was lost, indicating that Smo protein accumulates uniformly in the absence of Ptc activity (Figure 2e ).
The simplest interpretation of these data is that Ptc functions to block the translation or promote the degradation of Smo. And, as the spatial distribution of Smo was unaltered in h-Gal4;UAS-smo transgenic embryos, it would follow that Ptc activity can suppress accumulation of Smo protein independently of the levels at which the gene is transcribed. This effect of Hh/Ptc-mediated signalling on Smo accumulation provides a simple explanation for the lack of an effect of ectopic smo expression, namely that the exogenous protein never accumulates outside the normal domain of Smo activity.
Surprisingly, however, when h-Gal4;UAS-smo embryos were probed with the anti-FLAG antibody, a strikingly different pattern of exogenous protein accumulation was observed (Figure 3a,b) . In contrast to the narrow stripes detected by the anti-SmoC antibody, staining was seen throughout each h-Gal4 expression domain. This indicates that the smo mRNA is translated in all cells in which it is transcribed. It follows that the Ptc-dependent staining pattern revealed by the anti-SmoC antibody reflects a posttranslational modification of the Smo protein. One possibility is that Ptc could promote the cleavage of Smo, yielding a relatively stable but functionally inert truncated form of the protein in cells not exposed to Hh. In this connection, it is interesting to note that the SREPB cleavage activating protein (SCAP), with which Ptc shares some homology, acts to promote the cleavage of SREBP [21] by chaperoning the latter from the endoplasmic reticulum to the Golgi [22, 23] . Alternatively, however, it could be that Ptc induces a modification of the Smo protein that masks the epitope recognised by the anti-SmoC antibody; binding of Hh to Ptc would suppress this modification, activating the protein and making it accessible to the antibody. To discriminate between these two possibilities, we generated a Brief Communication 1317 second tagged form of Smo, in this case inserting a haemagglutinin (HA) tag at the end of the carboxy-terminal tail (see Figure 3d ). When embryos expressing this construct under h-Gal4 control were stained with an anti-HA antibody, a similar broad distribution of the tagged protein to that revealed by the anti-FLAG antibody was seen (Figure 3c ). This argues against the cleavage model, but instead suggests that the carboxy-terminal tail undergoes a Ptc-dependent modification. As our anti-SmoC antibody was raised against an unmodified bacterially expressed protein, it seems most likely that this modification results in a conformational change that exposes epitopes recognised by the antibody. In this regard, it is notable that a putative dominant gain-of-function mutation in the human Smo protein is predicted to change the conformation of the equivalent region of the carboxy-terminal tail against which the anti-SmoC antibody is directed [24] .
Materials and methods

Generation of epitope tagged Smo transgenes
A full-length smo cDNA was assembled from genomic clones [6] . A fragment encoding the prolactin signal peptide and FLAG tag was amplified from thrombin receptor cDNA (a generous gift from Shaun R. Coughlin, University of California at San Francisco) and used to replace the endogenous sequence encoding Smo signal peptide. The smo-HA transgene was generated by cloning the triple HA tag present in the shuttle plasmid pRD67 [11] into the XhoI site of the smo cDNA.
Generation and purification of anti-Smo antibody
A fragment that encodes a region of the carboxy-terminal tail of Smo from residues 646 to 881 was amplified from the smo cDNA and ligated in-frame with NdeI/BamHI-digested pET14b (Novagen). ITPG induction of bacteria transformed with this plasmid yielded a His-tagged fusion protein of ~30 kD. Inclusion bodies were purified from induced cultures following standard protocols [25] and used to immunise rabbits. Antibodies specific for Smo were purified from the serum by immunoaffinity purification [25] using the bacterially expressed fragment fusion protein coupled to an NHS-activated Sepharose column (Hi Trap NHS-activated, Amersham-Pharmacia Biotech). Acidic and basic elutions were pooled and concentrated using an Amicon concentrator.
Antibody stainings and microscopy
Embryos were fixed and stained using standard protocols. The affinitypurified anti-Smo antibody was used at 1:50-1:100. Monoclonal anti-FLAG antibodies M1 and M2 (Sigma) were used at a dilution of 1:200. Monoclonal anti-En (4D9) and anti-Wg (4D4) were used at 1:100 dilution. Monoclonal anti-β-galactosidase was used at 1:1000. Specimens were examined and photographed using a Zeiss Axioplan 2 microscope. Figures were composed using Adobe Photoshop 4.0 software on Macintosh computers.
Supplementary material
Supplementary material including full methodological details is available at http://current-biology.com/supmat/supmatin.htm.
